You are here

Industry Trends

Findings raise concern about money’s influence on evidence base
Controversial topic gets spotlight at Critical Care Congress
Drug makers “game” the system, report finds
Impax autoinjector has a cash price 80% lower than Mylan’s EpiPen
The initiative aims to leverage blockchain technology to improve public health
President-elect’s remarks energize thimerosal opponents
Readmission rates “slightly but significantly” better for ACO-affiliated centers
American Cancer Society issues annual report
Tort reform takes center stage in Obamacare replacement plan
Company boosts prices on nine key products in 2017
Organizations try cost-cutting spin-offs
Company accused of hiding bone-growth product’s adverse affects